Table 1 Demographic features, disease onset, diagnosis, duration, and clinical features among adolescent girls with autoimmune rheumatic diseases
From: Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases
| Â | Adolescent girls with autoimmune rheumatic diseases | |||
|---|---|---|---|---|
Total (n = 52) | JSLE (n = 21) | JIA (n = 23) | JDM (n = 8) | |
Median (Minimum to Maximum) | ||||
Current age (years) | 15 (13-17.5) | 16 (14-17.5) | 14 (13–17) | 15 (14-16.5) |
BMI | 22 (17–32) | 21.5 (18–30) | 23.7 (17–32) | 22 (18–23) |
Age of disease onset (years) *# | 12 (4–16) | 13 (8–16) | 11 (4-14.5) | 9.5 (8–11) |
Age of disease diagnosis (years) * | 12.5 (5–16) | 13 (7–16) | 11 (5–15) | 10 (10–13) |
Duration of disease (years) *#@ | 3 (0.2–10) | 2 (0.2-5) | 4 (1–10) | 5.8 (4–7) |
Clinical features N (%) | Â | Â | Â | Â |
Fever | 9 (17.3) | 5 (23.8) | 3 (13.0) | 1 (12.5) |
Weight loss | 4 (7.7) | 4 (19.0) | 0 (0.0) | 0 (0.0) |
Fatigue | 22 (42.3) | 17 (81.0) | 3(13.0) | 2(25.0) |
Lymphadenopathy | 1 (1.9) | 1 (4.8) | 0 (0.0) | 0 (0.0) |
Mucocutaneous | 15 (28.8) | 12(57.1) | 0 (0.0) | 3(37.5) |
Eye disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Myositis | 6 (11.5) | 3(14.3) | 1(4.3) | 2(25.0) |
Cardiopulmonary | 5 (9.6) | 4(19.0) | 0 (0.0) | 1(12.5) |
GIT | 1 (1.9) | 0 (0.0) | 1(4.3) | 0 (0.0) |
CNS | 3 (5.8) | 3(14.3) | 0 (0.0) | 0 (0.0) |
Renal | 6 (11.5) | 6(28.6) | 0 (0.0) | 0 (0.0) |
Arthritis/arthralgia | 42 (80.8) | 19 (90.5) | 20 (87.0) | 3(37.5) |